| Financial Year |
March 31 2023 |
| Monetary Funds |
1,949,046,535.48 |
| Held-for-trading Financial Assets |
68,392,830.21 |
| Notes Receivable |
-- |
| Accounts Receivable |
117,303,837.65 |
| Advances to Suppliers |
10,078,364.03 |
| Other Receivables |
14,736,450.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,864,784,648.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
122,928.40 |
| Other Current Assets |
402,265,076.01 |
| Total Current Assets |
11,426,730,671.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,658,101,004.90 |
| Investment Properties |
7,793,071,116.67 |
| Fixed Assetes |
10,383,996.17 |
| Under-construction Projects |
7,582,543.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
916,040.20 |
| R&D expenses |
-- |
| Goodwill |
56,085,152.40 |
| Long-Term Deferred and Prepaid Expenses |
15,327,912.47 |
| Deferred Income Tax Assets |
61,300,050.82 |
| Other Non-Current Assets |
33,009,920.00 |
| Sub-Total of Non-Current Assets |
10,619,441,856.45 |
| Total Assets |
22,046,172,527.78 |
| Short-Term Loans |
2,630,949,657.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,031,838,788.47 |
| Accounts Received In Advance |
68,183,058.95 |
| Employee Compensation Payable |
3,529,138.16 |
| Taxes Payable |
68,765,419.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,041,894,109.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,444,548,128.88 |
| Other Current Liabilities |
213,169,733.90 |
| Sub-Total of Current Liabilities |
7,957,708,649.05 |
| Long-term Loans |
2,485,610,149.16 |
| Bonds Payable |
2,985,075,958.76 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
79,640,035.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,621,021,676.09 |
| Total Liabilities |
13,578,730,325.14 |
| Paid-In Capital(Or Share Stock) |
1,873,304,804.00 |
| Capital Surplus |
3,121,943,598.41 |
| Surplus Reserve |
182,019,457.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,382,164,865.40 |
| Minority Stockholder's Interest |
1,908,009,477.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,559,432,725.38 |
| Owner's Equity（Stockholder's Equity） |
8,467,442,202.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,046,172,527.78 |
